Infant cold medicines pulled from market
The makers of more than one dozen over-the-counter infant cough and cold medicines are voluntarily pulling the products from the U.S. market.
The withdrawal comes on the heels of reports by the U.S. Food and Drug Administration suggesting some of the medicines were associated with serious side effects and some deaths in patients younger than 6, The New York Times said Thursday.
The Consumer Healthcare Products Association, which represents over-the-counter drug makers, said the voluntary withdrawal affects only "infant" oral medicines, not those intended and labeled for use in children age 2 and older.
The brands include Dimetapp, Little Colds, Pediacare, Robitussin, Triaminic and Tylenol.
"It’s important to point out that these medicines are safe and effective when used as directed, and most parents are using them appropriately," CHPA president Linda A. Suydam said Thursday in a release.
The trade group is recommending that the FDA change labels on children’s cough and cold medicines from "ask a doctor" before using to "do not use" in children under 2. // Copyright 2007 by United Press International
- Female circumcision is banned in Kurdistan, Iraq
- Quake-striken Haitians grow desperate for food, supplies
- 3 US Based Scientists Capture the 2009 Nobel Prize in Medicine
- Quantum laser nanoantenna demonstrated
- Quantum laser nanoantenna demonstrated
- Infant cold medicines pulled from market
- Report questions Lyme disease treatment
- Doc suggests opium for medicinal heroin
- Naked photo shoot planned for Mexico City
- Kerry Katona expecting another girl
- Anna Nicole Smith's body in morgue amid court fight
- Johnny Knoxville has confessed he has a small penis
- Nude Britney Spears on Bearskin Rug
- Captive Natascha Kampusch was sexually abused - Images
- Angelina Jolie till sleeps with Jenny Shimizu
- Fire of raunchy photos Katie Rees Miss Nevada
- Sex scandal: Romanian consul in Moldova caught on tape
- World's smallest baby to be released from hospital